Truist raised the firm’s price target on Sila Realty Trust (SILA) to $28 from $27 and keeps a Buy rating on the shares. The company appears well positioned amid macroeconomic uncertainty as a triple-net healthcare REIT with 3.3-times net debt to EBITDA, no debt maturities until 2027, 96% occupancy, and only 2% of leases expiring in 2025, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SILA:
